Sarepta Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a developer of innovative RNA-targeted therapeutics, granted equity awards on September 30, 2015, that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2014 Employment Commencement Incentive Plan, as a material inducement to employment to six individuals hired by Sarepta in September 2015. The equity awards were approved in accordance with NASDAQ Listing Rule 5635(c)(4).

Help employers find you! Check out all the jobs and post your resume.